Contact Us

CDC and FDA have recommended that the use of Johnson & Johnson’s Janssen (J&J/Janssen) COVID-19 Vaccine may resume in the United States, effective April 23, 2021. However, women, especially those under 50 years old, should be aware of the rare risk of blood clots with low platelets after vaccination, and that other COVID-19 vaccines are available where this risk has not been seen. If you received a J&J/Janssen vaccine, here is what you need to know. Read the CDC/FDA statement.